513 related articles for article (PubMed ID: 34163488)
21. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
Choreño-Parra JA; Jiménez-Álvarez LA; Cruz-Lagunas A; Rodríguez-Reyna TS; Ramírez-Martínez G; Sandoval-Vega M; Hernández-García DL; Choreño-Parra EM; Balderas-Martínez YI; Martinez-Sánchez ME; Márquez-García E; Sciutto E; Moreno-Rodríguez J; Barreto-Rodríguez JO; Vázquez-Rojas H; Centeno-Sáenz GI; Alvarado-Peña N; Salinas-Lara C; Sánchez-Garibay C; Galeana-Cadena D; Hernández G; Mendoza-Milla C; Domínguez A; Granados J; Mena-Hernández L; Pérez-Buenfil LÁ; Domínguez-Cheritt G; Cabello-Gutiérrez C; Luna-Rivero C; Salas-Hernández J; Santillán-Doherty P; Regalado J; Hernández-Martínez A; Orozco L; Ávila-Moreno F; García-Latorre EA; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
Front Immunol; 2021; 12():593595. PubMed ID: 33995342
[TBL] [Abstract][Full Text] [Related]
22. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.
To KK; Hung IF; Li IW; Lee KL; Koo CK; Yan WW; Liu R; Ho KY; Chu KH; Watt CL; Luk WK; Lai KY; Chow FL; Mok T; Buckley T; Chan JF; Wong SS; Zheng B; Chen H; Lau CC; Tse H; Cheng VC; Chan KH; Yuen KY
Clin Infect Dis; 2010 Mar; 50(6):850-9. PubMed ID: 20136415
[TBL] [Abstract][Full Text] [Related]
23. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
[TBL] [Abstract][Full Text] [Related]
24. Association Between Low Zinc Levels and Severity of Acute Respiratory Distress Syndrome by New Coronavirus SARS-CoV-2.
Gonçalves TJM; Gonçalves SEAB; Guarnieri A; Risegato RC; Guimarães MP; de Freitas DC; Razuk-Filho A; Junior PBB; Parrillo EF
Nutr Clin Pract; 2021 Feb; 36(1):186-191. PubMed ID: 33368619
[TBL] [Abstract][Full Text] [Related]
25. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
[TBL] [Abstract][Full Text] [Related]
26. Plasma TNFSF13B and TNFSF14 Function as Inflammatory Indicators of Severe Adenovirus Pneumonia in Pediatric Patients.
Fan H; Lu B; Cao C; Li H; Yang D; Huang L; Ding T; Wu M; Lu G
Front Immunol; 2020; 11():614781. PubMed ID: 33542721
[TBL] [Abstract][Full Text] [Related]
27. Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19.
Hasegawa T; Nakagawa A; Suzuki K; Yamashita K; Yamashita S; Iwanaga N; Tamada E; Noda K; Tomii K
Cytokine; 2021 Dec; 148():155618. PubMed ID: 34127355
[TBL] [Abstract][Full Text] [Related]
28. Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
Karaba AH; Zhou W; Hsieh LL; Figueroa A; Massaccesi G; Rothman RE; Fenstermacher KZJ; Sauer L; Shaw-Saliba K; Blair PW; Robinson ML; Leung S; Wesson R; Alachkar N; El-Diwany R; Ji H; Cox AL
Clin Infect Dis; 2022 Jan; 74(2):254-262. PubMed ID: 34013339
[TBL] [Abstract][Full Text] [Related]
29. Cytokine and chemokine profiles in the sera of COVID-19 patients with different stages of severity.
Bourhis M; Idir A; Machraoui S; Hachimi A; Elouardi Y; Jamil O; Khallouki M; Zahlane K; Guennouni M; Hazime R; Essaadouni L; Lourhlam B; Ennaji MM; Mouse HA; Admou B; Zyad A
Cytokine; 2024 Aug; 180():156653. PubMed ID: 38781873
[TBL] [Abstract][Full Text] [Related]
30. Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.
Deng LS; Yuan J; Ding L; Chen YL; Zhao CH; Chen GQ; Li XH; Li XH; Luo WT; Lan JF; Tan GY; Tang SH; Xia JY; Liu X
Infect Dis Poverty; 2020 Dec; 9(1):163. PubMed ID: 33261654
[TBL] [Abstract][Full Text] [Related]
31. Serum Inflammatory Markers in Patients with Adenovirus Respiratory Infection.
Sun J; Xiao Y; Zhang M; Ao T; Lang S; Wang J
Med Sci Monit; 2018 Jun; 24():3848-3855. PubMed ID: 29877315
[TBL] [Abstract][Full Text] [Related]
32. Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study.
Krysko O; Kondakova E; Vershinina O; Galova E; Blagonravova A; Gorshkova E; Bachert C; Ivanchenko M; Krysko DV; Vedunova M
Front Immunol; 2021; 12():715072. PubMed ID: 34539644
[TBL] [Abstract][Full Text] [Related]
33. The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes.
Guo J; Huang F; Liu J; Chen Y; Wang W; Cao B; Zou Z; Liu S; Pan J; Bao C; Zeng M; Xiao H; Gao H; Yang S; Zhao Y; Liu Q; Zhou H; Zhu J; Liu X; Liang W; Yang Y; Zheng S; Yang J; Diao H; Su K; Shao L; Cao H; Wu Y; Zhao M; Tan S; Li H; Xu X; Wang C; Zhang J; Wang L; Wang J; Xu J; Li D; Zhong N; Cao X; Gao GF; Li L; Jiang C
Sci Rep; 2015 Jun; 5():10942. PubMed ID: 26028236
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
[TBL] [Abstract][Full Text] [Related]
35. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
Copaescu A; James F; Mouhtouris E; Vogrin S; Smibert OC; Gordon CL; Drewett G; Holmes NE; Trubiano JA
Front Immunol; 2021; 12():646095. PubMed ID: 33815405
[TBL] [Abstract][Full Text] [Related]
36. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
Petrone L; Petruccioli E; Vanini V; Cuzzi G; Najafi Fard S; Alonzi T; Castilletti C; Palmieri F; Gualano G; Vittozzi P; Nicastri E; Lepore L; Antinori A; Vergori A; Caccamo N; Cantini F; Girardi E; Ippolito G; Grifoni A; Goletti D
Clin Microbiol Infect; 2021 Feb; 27(2):286.e7-286.e13. PubMed ID: 33045370
[TBL] [Abstract][Full Text] [Related]
37. Cytokine markers as predictors of type of respiratory infection in patients during the influenza season.
Haran JP; Buglione-Corbett R; Lu S
Am J Emerg Med; 2013 May; 31(5):816-21. PubMed ID: 23481156
[TBL] [Abstract][Full Text] [Related]
38. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
[TBL] [Abstract][Full Text] [Related]
39. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
Wang X; Kerkmann L; Hetzel M; Windmann S; Trilling M; Zhang W; Ehrhardt A; Bayer W
J Virol; 2022 Nov; 96(22):e0113322. PubMed ID: 36342295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
